Synagis 100 MG/ML vialml
Ended Awarded
- Contract number
- SPE2DB25FGSR1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,795
Award facts
- Contract value 100% obligated
- $47,794.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 22, 2025, by the Defense Logistics Agency (DLA) for the supply of Synagis 100 mg/mL vials. The contract, valued at $47,794.80 with a firm fixed-price structure, is scheduled for completion by October 14, 2025. This award was issued as a competitive delivery order without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026.
Synagis (palivizumab) is a monoclonal antibody immunization used primarily for respiratory syncytial virus (RSV) prophylaxis in high-risk pediatric populations, making this delivery order part of the broader military healthcare supply chain. The award underscores AmerisourceBergen's critical role as a pharmaceutical prime vendor for federal medical procurement, supporting Defense Health Agency operations and other government healthcare systems. The company's extensive federal contract portfolio reflects its capability to manage specialized pharmaceutical commodities and maintain reliable supply chains for military and veteran healthcare programs on a global scale.
Quick answers
Who was awarded contract SPE2DB25FGSR1?
SPE2DB25FGSR1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FGSR1 worth?
The government has obligated $47,795 on SPE2DB25FGSR1.
Is contract SPE2DB25FGSR1 an order under another contract?
Yes. SPE2DB25FGSR1 is a delivery order under SPE2DB20D7059, an indefinite delivery contract.
Was contract SPE2DB25FGSR1 competed?
The extent of competition for SPE2DB25FGSR1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award